Paris, France

Melissanne De Wispelaere

This inventor holds 2 USPTO granted patents. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melissanne De Wispelaere. Retrieved from https://idiyas.com/inventor/melissanne-de-wispelaere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Melissanne De Wispelaere: Innovator in Immunogenic Composition

Introduction

Melissanne De Wispelaere is a notable inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly through his innovative work on lentiviral vector-based compositions.

Latest Patents

De Wispelaere holds two patents, both focused on a lentiviral vector-based Japanese encephalitis (JE) immunogenic composition. These inventions involve a recombinant lentiviral vector that expresses the precursor of membrane (prM) and the envelope (E) protein of the Japanese encephalitis virus (JEV). The patents also detail methods to prevent JEV infection in mammalian hosts, including humans and domestic pigs.

Career Highlights

Throughout his career, Melissanne De Wispelaere has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing the understanding of viral immunogenic compositions.

Collaborations

He has collaborated with esteemed colleagues, including Pierre Charneau and Philippe Despres, contributing to the advancement of immunological research.

Conclusion

Melissanne De Wispelaere's innovative work in the field of immunogenic compositions highlights his significant role as an inventor. His contributions continue to impact the scientific community and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…